Peter Valentin Tomazic1, Ruth Birner-Gruenberger2, Anita Leitner3, Britta Obrist4, Stefan Spoerk5, Doris Lang-Loidolt3. 1. ENT-University Hospital, Medical University of Graz, Graz, Austria. Electronic address: peter.tomazic@medunigraz.at. 2. Institute of Pathology, Medical University of Graz, Graz, Austria; Center of Medical Research, Mass Spectrometry Core Facility, Medical University of Graz, Graz, Austria; Austrian Center of Industrial Biotechnology, Graz, Austria; Omics Center Graz, Graz, Austria. Electronic address: ruth.birner-gruenberger@medunigraz.at. 3. ENT-University Hospital, Medical University of Graz, Graz, Austria. 4. Center of Medical Research, Mass Spectrometry Core Facility, Medical University of Graz, Graz, Austria; Austrian Center of Industrial Biotechnology, Graz, Austria; Omics Center Graz, Graz, Austria. 5. Center of Medical Research, Mass Spectrometry Core Facility, Medical University of Graz, Graz, Austria.
Abstract
BACKGROUND: Nasal mucus is the first-line defense barrier against (aero-) allergens. However, its proteome and function have not been clearly investigated. OBJECTIVE: The role of nasal mucus in the pathophysiology of allergic rhinitis was investigated by analyzing its proteome in patients with allergic rhinitis (n = 29) and healthy control subjects (n = 29). METHODS: Nasal mucus was collected with a suction device, tryptically digested, and analyzed by using liquid chromatography-tandem mass spectrometry. Proteins were identified by searching the SwissProt database and annotated by collecting gene ontology data from databases and existing literature. Gene enrichment analysis was performed by using Cytoscape/BINGO software tools. Proteins were quantified with spectral counting, and selected proteins were confirmed by means of Western blotting. RESULTS: In total, 267 proteins were identified, with 20 (7.5%) found exclusively in patients with allergic rhinitis and 25 (9.5%) found exclusively in healthy control subjects. Five proteins were found to be significantly upregulated in patients with allergic rhinitis (apolipoprotein A-2 [APOA2], 9.7-fold; α2-macroglobulin [A2M], 4.5-fold; apolipoprotein A-1 [APOA1], 3.2-fold; α1-antitrypsin [SERPINA1], 2.5-fold; and complement C3 [C3], 2.3-fold) and 5 were found to be downregulated (antileukoproteinase [SLPI], 0.6-fold; WAP 4-disulfide core domain protein [WFDC2], 0.5-fold; haptoglobin [HP], 0.7-fold; IgJ chain [IGJ], 0.7-fold; and Ig hc V-III region BRO, 0.8-fold) compared with levels seen in healthy control subjects. CONCLUSION: The allergic rhinitis mucus proteome shows an enhanced immune response in which apolipoproteins might play an important role. Furthermore, an imbalance between cysteine proteases and antiproteases could be seen, which negatively affects epithelial integrity on exposure to pollen protease activity. This reflects the important role of mucus as the first-line defense barrier against allergens.
BACKGROUND: Nasal mucus is the first-line defense barrier against (aero-) allergens. However, its proteome and function have not been clearly investigated. OBJECTIVE: The role of nasal mucus in the pathophysiology of allergic rhinitis was investigated by analyzing its proteome in patients with allergic rhinitis (n = 29) and healthy control subjects (n = 29). METHODS: Nasal mucus was collected with a suction device, tryptically digested, and analyzed by using liquid chromatography-tandem mass spectrometry. Proteins were identified by searching the SwissProt database and annotated by collecting gene ontology data from databases and existing literature. Gene enrichment analysis was performed by using Cytoscape/BINGO software tools. Proteins were quantified with spectral counting, and selected proteins were confirmed by means of Western blotting. RESULTS: In total, 267 proteins were identified, with 20 (7.5%) found exclusively in patients with allergic rhinitis and 25 (9.5%) found exclusively in healthy control subjects. Five proteins were found to be significantly upregulated in patients with allergic rhinitis (apolipoprotein A-2 [APOA2], 9.7-fold; α2-macroglobulin [A2M], 4.5-fold; apolipoprotein A-1 [APOA1], 3.2-fold; α1-antitrypsin [SERPINA1], 2.5-fold; and complement C3 [C3], 2.3-fold) and 5 were found to be downregulated (antileukoproteinase [SLPI], 0.6-fold; WAP 4-disulfide core domain protein [WFDC2], 0.5-fold; haptoglobin [HP], 0.7-fold; IgJ chain [IGJ], 0.7-fold; and Ig hc V-III region BRO, 0.8-fold) compared with levels seen in healthy control subjects. CONCLUSION: The allergic rhinitis mucus proteome shows an enhanced immune response in which apolipoproteins might play an important role. Furthermore, an imbalance between cysteine proteases and antiproteases could be seen, which negatively affects epithelial integrity on exposure to pollen protease activity. This reflects the important role of mucus as the first-line defense barrier against allergens.
Authors: Juliana Durack; Susan V Lynch; Snehal Nariya; Nirav R Bhakta; Avraham Beigelman; Mario Castro; Anne-Marie Dyer; Elliot Israel; Monica Kraft; Richard J Martin; David T Mauger; Sharon R Rosenberg; Tonya Sharp-King; Steven R White; Prescott G Woodruff; Pedro C Avila; Loren C Denlinger; Fernando Holguin; Stephen C Lazarus; Njira Lugogo; Wendy C Moore; Stephen P Peters; Loretta Que; Lewis J Smith; Christine A Sorkness; Michael E Wechsler; Sally E Wenzel; Homer A Boushey; Yvonne J Huang Journal: J Allergy Clin Immunol Date: 2016-11-10 Impact factor: 10.793
Authors: Caitlin E Anderson; Joshua R Buser; Alexis M Fleming; Eva-Maria Strauch; Paula D Ladd; Janet Englund; David Baker; Paul Yager Journal: Lab Chip Date: 2019-02-26 Impact factor: 6.799
Authors: Jennifer E Douglas; Cailu Lin; Corrine J Mansfield; Charles J Arayata; Beverly J Cowart; Andrew I Spielman; Nithin D Adappa; James N Palmer; Noam A Cohen; Danielle R Reed Journal: Chem Senses Date: 2019-01-01 Impact factor: 3.160
Authors: Bernhard Krismer; Christopher Weidenmaier; Alexander Zipperer; Andreas Peschel Journal: Nat Rev Microbiol Date: 2017-10-12 Impact factor: 60.633
Authors: Nam Soo Joo; Idil Apak T Evans; Hyung-Ju Cho; Il-Ho Park; John F Engelhardt; Jeffrey J Wine Journal: PLoS One Date: 2015-02-23 Impact factor: 3.240